Neurobiological effects of phospholipids
Neurodevelopment
Neuroprotection
Phospholipids
Stress
Journal
Neurobiology of stress
ISSN: 2352-2895
Titre abrégé: Neurobiol Stress
Pays: United States
ID NLM: 101643409
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
02
07
2020
revised:
11
09
2020
accepted:
11
09
2020
entrez:
21
12
2020
pubmed:
22
12
2020
medline:
22
12
2020
Statut:
epublish
Résumé
Nutrition is a crucial component for maintenance of brain function and mental health. Accumulating evidence suggests that certain molecular compounds derived from diet can exert neuroprotective effects against chronic stress, and moreover improve important neuronal processes vulnerable to the stress response, such as plasticity and neurogenesis. Phospholipids are naturally occurring amphipathic molecules with promising potential to promote brain health. However, it is unclear whether phospholipids are able to modulate neuronal function directly under a stress-related context. In this study, we investigate the neuroprotective effects of phosphatidylcholine (PC), lysophosphatidylcholine (LPC), phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylglycerol (PG), phosphatidic acid (PA), sphingomyelin (SM) and cardiolipin (CL) against corticosterone (CORT)-induced cytotoxicity in primary cultured rat cortical neurons. In addition, we examine their capacity to modulate proliferation and differentiation of hippocampal neural progenitor cells (NPCs). We show that PS, PG and PE can reverse CORT-induced cytotoxicity and neuronal depletion in cortical cells. On the other hand, phospholipid exposure was unable to prevent the decrease of
Identifiants
pubmed: 33344707
doi: 10.1016/j.ynstr.2020.100252
pii: S2352-2895(20)30042-4
pmc: PMC7739190
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100252Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
APC Microbiome Ireland has conducted studies in collaboration with several companies, including GSK, Pfzer, Cremo, Suntory, Wyeth, Mead Johnson, Nutricia, 4D Pharma, and DuPont. B. L. Roy is an employee of Cremo SA. T. G. Dinan has been an invited speaker at meetings organized by Servier, Lundbeck, Janssen, and AstraZeneca and has received research funding from Mead Johnson, Cremo, Nutricia, and 4D Pharma. J. F. Cryan has been an invited speaker at meetings organized by Mead Johnson, Yakult, Alkermes, and Janssen and has received research funding from Mead Johnson Nutrition, Cremo, Nutricia, DuPont, and 4D Pharma.
Références
Acta Pharmacol Sin. 2009 Apr;30(4):379-87
pubmed: 19343058
Cell Death Dis. 2018 Sep 20;9(10):945
pubmed: 30237546
Neurobiol Stress. 2014 Nov 21;1:147-55
pubmed: 27589664
Oncogene. 2010 Jan 7;29(1):139-49
pubmed: 19855431
Neurochem Res. 2008 Dec;33(12):2444-71
pubmed: 18629638
Endocr Rev. 2000 Feb;21(1):55-89
pubmed: 10696570
Rev Neurosci. 2018 Dec 19;30(1):1-7
pubmed: 29902157
Heliyon. 2017 Jun 09;3(6):e00318
pubmed: 28649667
J Neurochem. 2009 Mar;108(5):1251-65
pubmed: 19141071
Front Physiol. 2015 Aug 19;6:230
pubmed: 26347657
Med Hypotheses. 2017 Sep;107:55-63
pubmed: 28915964
Nutrients. 2010 Feb;2(2):116-27
pubmed: 22254012
Biol Psychiatry. 2017 Dec 15;82(12):914-923
pubmed: 28629541
J Biol Chem. 2007 Sep 14;282(37):27155-64
pubmed: 17636253
Nutr Neurosci. 2019 Sep 16;:1-10
pubmed: 31524100
Science. 1997 Oct 17;278(5337):477-83
pubmed: 9334309
Evid Based Complement Alternat Med. 2012;2012:605303
pubmed: 22919414
Nutr Res Rev. 2016 Dec;29(2):163-171
pubmed: 27364160
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5573-8
pubmed: 18391224
Life Sci. 2007 Jan 16;80(6):530-7
pubmed: 17074364
Psychiatry Investig. 2010 Dec;7(4):231-5
pubmed: 21253405
J Neurosci. 2008 Nov 12;28(46):11785-91
pubmed: 19005040
J Cell Mol Med. 2008 Oct;12(5B):1872-84
pubmed: 18363840
Public Health Nutr. 2015 Aug;18(11):2074-93
pubmed: 25465596
Pharmacogenet Genomics. 2013 Jun;23(6):301-13
pubmed: 23619509
J Physiol Paris. 2014 Sep-Dec;108(4-6):286-91
pubmed: 24819880
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1484-90
pubmed: 18547700
BMC Psychiatry. 2014 May 09;14:132
pubmed: 24884515
Front Immunol. 2016 Nov 29;7:544
pubmed: 27965671
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3573-8
pubmed: 23401542
Int J Neuropsychopharmacol. 2015 Dec 12;19(6):
pubmed: 26657646
Biol Psychiatry. 2008 Sep 15;64(6):527-32
pubmed: 18571629
Drug Test Anal. 2016 Oct;8(10):1039-1048
pubmed: 26810883
Brain Res. 2020 Jan 15;1727:146567
pubmed: 31783002
Mol Psychiatry. 2017 Apr;22(4):527-536
pubmed: 27528460
Int J Neurosci. 2019 Jun;129(6):598-611
pubmed: 30433866
J Neurochem. 1991 Jun;56(6):1864-72
pubmed: 2027004
Acta Neurobiol Exp (Wars). 2008;68(2):131-8
pubmed: 18511949
Neurosci Biobehav Rev. 2020 Apr;111:183-193
pubmed: 31945391
Nat Rev Neurosci. 2017 Jun;18(6):335-346
pubmed: 28469276
Nutrition. 2015 Jun;31(6):781-6
pubmed: 25933483
FASEB J. 2018 Feb;32(2):613-624
pubmed: 28970252
Nutrients. 2019 Dec 06;11(12):
pubmed: 31817768
J Biol Chem. 2005 Nov 4;280(44):36815-23
pubmed: 16115865
Adv Nutr. 2017 Nov 15;8(6):804-811
pubmed: 29141966
Int J Neuropsychopharmacol. 2019 Dec 1;22(12):765-777
pubmed: 31812985
Stress. 2004 Jun;7(2):119-26
pubmed: 15512856
Am J Clin Nutr. 2009 Oct;90(4):1056-60
pubmed: 19656836
J Neurochem. 2012 Mar;120(6):964-73
pubmed: 22192001
Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80
pubmed: 18752720
Cold Spring Harb Perspect Biol. 2012 Sep 01;4(9):a011189
pubmed: 22952397
Endocr Metab Immune Disord Drug Targets. 2019;19(6):874-884
pubmed: 30760195
Pharmacol Biochem Behav. 2014 Dec;127:1-6
pubmed: 25316305
Eur J Nutr. 2019 Apr;58(3):931-945
pubmed: 30298207
Molecules. 2017 Nov 14;22(11):
pubmed: 29135918
Brain Behav Immun. 2013 Jan;27(1):22-32
pubmed: 22985767
Curr Pharm Des. 2004;10(8):915-21
pubmed: 15032694
PLoS One. 2018 Jan 26;13(1):e0192083
pubmed: 29373584
Nat Med. 1998 Nov;4(11):1313-7
pubmed: 9809557
BMC Pharmacol Toxicol. 2019 Sep 9;20(1):56
pubmed: 31500666
Pediatr Res. 2015 Jan;77(1-2):148-55
pubmed: 25314585
Future Med Chem. 2011 Apr;3(5):549-65
pubmed: 21526896
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nutrition. 2019 Jan;57:183-193
pubmed: 30172995
Cell Death Differ. 2005 Oct;12(10):1329-43
pubmed: 15905876
Acta Biochim Biophys Sin (Shanghai). 2015 Nov;47(11):915-24
pubmed: 26423115
Eur Neuropsychopharmacol. 2019 Dec;29(12):1321-1332
pubmed: 31735529
Nutrients. 2019 Nov 13;11(11):
pubmed: 31766273
Trends Mol Med. 2018 Jun;24(6):521-522
pubmed: 29699864
Neurobiol Aging. 2020 Sep;93:52-54
pubmed: 32450444
Nat Methods. 2005 May;2(5):333-6
pubmed: 15846359
Nature. 2003 Oct 30;425(6961):962-7
pubmed: 14574365
BMB Rep. 2018 Aug;51(8):400-405
pubmed: 30037364
Stem Cell Reports. 2017 Jun 6;8(6):1743-1756
pubmed: 28591654
BMC Med. 2013 Jan 03;11:3
pubmed: 23286788
Int J Mol Sci. 2012 Nov 21;13(11):15401-19
pubmed: 23203133
Behav Brain Res. 2018 Sep 3;349:1-7
pubmed: 29715537
Front Cell Neurosci. 2017 Aug 16;11:237
pubmed: 28860968
Nutr Neurosci. 2001;4(3):169-78
pubmed: 11842886
Mol Neurobiol. 2018 Jan;55(1):445-461
pubmed: 27966075
Brain Res. 2017 Jun 15;1665:1-21
pubmed: 28396009
J Membr Biol. 2015 Aug;248(4):651-69
pubmed: 25675910
Neurology. 1991 May;41(5):644-9
pubmed: 2027477
Nat Rev Neurosci. 2008 Jul;9(7):568-78
pubmed: 18568016
Am J Clin Nutr. 2007 Feb;85(2):614S-620S
pubmed: 17284765
Lipids Health Dis. 2012 Jan 05;11:3
pubmed: 22221489
Trends Neurosci. 2008 Sep;31(9):464-8
pubmed: 18675469
J Neurosci Res. 2010 Aug 1;88(10):2091-102
pubmed: 20336774